Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
March 3, 2026
The future of PCOS management: Disease modification through regenerative, metabolic, and digital therapeutics
RA
Ruhi Arisha
SS
Shivam Sengupta
HD
Hitesh Kumar Dewangan
Chandigarh University
Ver todo
Puntos clave
Disease modification through metabolic intervention improves insulin resistance in PCOS.
Patients using digital therapeutics show better engagement and lifestyle changes over time.
Regenerative therapeutics may balance hormonal levels more effectively than traditional methods.
These findings suggest a paradigm shift in how PCOS is managed and treated.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Arisha et al. (Thu,) studied this question.
synapsesocial.com/papers/69a76808badf0bb9e87e3560
https://doi.org/https://doi.org/10.1016/j.prp.2026.156397
The future of PCOS management: Disease modification through regenerative, metabolic, and digital therapeutics | Synapse